{"id":"https://openalex.org/W2580248382","doi":"https://doi.org/10.1182/blood.v118.21.768.768","title":"Phase I Trial of the Targeted Alpha-Particle Nano-Generator Actinium-225 (225Ac)-Lintuzumab (Anti-CD33; HuM195) in Acute Myeloid Leukemia (AML)","display_name":"Phase I Trial of the Targeted Alpha-Particle Nano-Generator Actinium-225 (225Ac)-Lintuzumab (Anti-CD33; HuM195) in Acute Myeloid Leukemia (AML)","publication_year":2011,"publication_date":"2011-11-18","ids":{"openalex":"https://openalex.org/W2580248382","doi":"https://doi.org/10.1182/blood.v118.21.768.768","mag":"2580248382"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v118.21.768.768","doi":"https://doi.org/10.1182/blood.v118.21.768.768","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v118.21.768.768","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055703943","display_name":"Joseph Gerard Jurcic","orcid":"https://orcid.org/0000-0002-1671-9998","observed_orcids":["https://orcid.org/0000-0002-1671-9998"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph G. Jurcic","raw_affiliation_strings":["Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044188379","display_name":"Todd Louis Rosenblat","orcid":"https://orcid.org/0000-0002-9769-4832","observed_orcids":["https://orcid.org/0000-0002-9769-4832"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Todd L. Rosenblat","raw_affiliation_strings":["Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068912186","display_name":"Michael R. McDevitt","orcid":"https://orcid.org/0000-0002-8855-0917","observed_orcids":["https://orcid.org/0000-0002-8855-0917"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael R. McDevitt","raw_affiliation_strings":["Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010076893","display_name":"Neeta D. Pandit-Taskar","orcid":"https://orcid.org/0000-0003-1551-2036","observed_orcids":["https://orcid.org/0000-0003-1551-2036"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Neeta Pandit-Taskar","raw_affiliation_strings":["Nuclear Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuclear Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063044283","display_name":"Jorge A. Carrasquillo","orcid":"https://orcid.org/0000-0002-8513-5734","observed_orcids":["https://orcid.org/0000-0002-8513-5734"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jorge A. Carrasquillo","raw_affiliation_strings":["Nuclear Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuclear Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062753493","display_name":"Suzanne M. Chanel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Suzanne M. Chanel","raw_affiliation_strings":["Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074613287","display_name":"Kevin Zikaras","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Zikaras","raw_affiliation_strings":["Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110103402","display_name":"Mark G. Frattini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark G. Frattini","raw_affiliation_strings":["Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077735185","display_name":"Peter George Maslak","orcid":"https://orcid.org/0000-0003-1949-5819","observed_orcids":["https://orcid.org/0000-0003-1949-5819"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter G. Maslak","raw_affiliation_strings":["Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064534601","display_name":"Dragan Cicic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138481","display_name":"Actinium Pharmaceuticals (United States)","ror":"https://ror.org/04zamhr10","country_code":"US","type":"company","lineage":["https://openalex.org/I4210138481"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Dragan Cicic","raw_affiliation_strings":["Actinium Pharmaceuticals, Inc., Newark, NJ, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Actinium Pharmaceuticals, Inc., Newark, NJ, USA,","institution_ids":["https://openalex.org/I4210138481"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015396908","display_name":"Steven M. Larson","orcid":"https://orcid.org/0000-0002-6111-7507","observed_orcids":["https://orcid.org/0000-0002-6111-7507"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Steven M. Larson","raw_affiliation_strings":["Nuclear Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuclear Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006680533","display_name":"David A. Scheinberg","orcid":"https://orcid.org/0000-0002-4160-923X","observed_orcids":["https://orcid.org/0000-0002-4160-923X","https://orcid.org/0009-0009-0651-7389"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Scheinberg","raw_affiliation_strings":["Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5010076893","https://openalex.org/A5015396908","https://openalex.org/A5062753493","https://openalex.org/A5063044283","https://openalex.org/A5064534601","https://openalex.org/A5068912186"],"corresponding_institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210138481"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":2.4452,"has_fulltext":false,"cited_by_count":45,"citation_normalized_percentile":{"value":0.87963644,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"118","issue":"21","first_page":"768","last_page":"768"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.028300000354647636,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-cd33-antibody","display_name":"anti-CD33 antibody","score":0.9679999947547913},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8809999823570251},{"id":"https://openalex.org/keywords/targeted-alpha-therapy","display_name":"targeted alpha therapy","score":0.8629999756813049},{"id":"https://openalex.org/keywords/bismuth-213","display_name":"bismuth-213","score":0.8600000143051147},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6610000133514404},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.9620000123977661},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.8769999742507935},{"id":"https://openalex.org/keywords/sepsis","display_name":"sepsis","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6952630877494812},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5351020097732544},{"id":"https://openalex.org/C2780873365","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukopenia","level":3,"score":0.5092161893844604},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4954766035079956},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48188215494155884},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.4695739448070526},{"id":"https://openalex.org/C176290653","wikidata":"https://www.wikidata.org/wiki/Q21114013","display_name":"CD33","level":4,"score":0.46078383922576904},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4565827250480652},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4417009949684143},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4395889937877655},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4217129945755005},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3677453398704529},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.32023540139198303},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.16074806451797485},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.11226215958595276},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08660179376602173},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.08451962471008301},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v118.21.768.768","doi":"https://doi.org/10.1182/blood.v118.21.768.768","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v118.21.768.768","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2520828414","https://openalex.org/W2123790660","https://openalex.org/W2755508849","https://openalex.org/W2061528942","https://openalex.org/W7007863822","https://openalex.org/W4220809790","https://openalex.org/W2690197079","https://openalex.org/W2519087020","https://openalex.org/W2573093668","https://openalex.org/W2514789970"],"abstract_inverted_index":{"Abstract":[0,1],"768":[2],"Background:":[3],"Lintuzumab,":[4],"a":[5,77,118,160,274,379,411],"humanized":[6],"anti-CD33":[7],"antibody,":[8],"targets":[9],"myeloid":[10],"leukemia":[11],"cells":[12],"and":[13,48,72,99,130,228,240,252,307,318,322,390],"has":[14,420],"modest":[15],"activity":[16,42,132,422],"against":[17],"AML.":[18,136],"To":[19],"increase":[20],"the":[21,32,52,127,192,196,238,403,434],"antibody's":[22],"potency":[23],"yet":[24],"avoid":[25],"nonspecific":[26],"cytotoxicity":[27],"seen":[28,44,213,248,313,362],"with":[29,147,314,335,387,410],"\u03b2-emitting":[30],"isotopes,":[31],"\u03b1-emitter":[33],"bismuth-213":[34],"(213Bi)":[35],"was":[36,43,191,205,212,247,288],"conjugated":[37,75],"to":[38,76,125,156,199,231,263,330,398,406,428,432],"lintuzumab.":[39],"Substantial":[40],"clinical":[41],"in":[45,86,102,135,214,222,233,249,270,343,363,417],"phase":[46,120],"I":[47,121],"II":[49],"trials,":[50],"but":[51,350],"use":[53],"of":[54,79,106,133,163,167,201,277,285,303,320,345,354,365,382,446,476],"213Bi":[55,97],"is":[56,402,415],"limited":[57,262],"by":[58,294],"its":[59],"46-min":[60],"half-life.":[61],"The":[62],"isotope":[63],"generator,":[64],"225Ac":[65],"(t\u00bd=10":[66],"days),":[67],"yields":[68],"4":[69,177,203,226,241,250,253,271,371,391],"\u03b1-emitting":[70],"isotopes":[71],"can":[73],"be":[74],"variety":[78],"antibodies":[80],"using":[81],"DOTA-SCN.":[82],"225Ac-labeled":[83],"immunoconjugates":[84],"kill":[85],"vitro":[87],"at":[88,91,165,237,297,352,370],"radioactivity":[89],"doses":[90,166,353],"least":[92],"1,000":[93],"times":[94],"lower":[95],"than":[96],"analogs":[98],"prolong":[100],"survival":[101],"mouse":[103],"xenograft":[104],"models":[105],"several":[107],"cancers":[108],"(McDevitt":[109],"et":[110],"al.":[111],"Science":[112],"2001).":[113],"Methods:":[114],"We":[115,290],"are":[116,328],"conducting":[117],"first-in-man":[119],"dose":[122,243,425],"escalation":[123],"trial":[124,430],"determine":[126],"safety,":[128],"pharmacology,":[129],"biological":[131],"225Ac-lintuzumab":[134,164,419],"Results:":[137],"Fifteen":[138],"patients":[139,235,254,348,368,375,385],"(median":[140],"age,":[141],"62":[142],"yrs;":[143],"range,":[144],"45\u201380":[145],"yrs)":[146],"relapsed":[148],"(n=10)":[149],"or":[150,176,448,478],"refractory":[151],"(n=5)":[152],"AML":[153],"were":[154,188,261,312,341,361],"treated":[155,236,386],"date.":[157],"Patients":[158],"received":[159],"single":[161],"infusion":[162],"0.5":[168],"(n=3),":[169,173,175],"1":[170,223],"(n=4),":[171],"2":[172,234,278,301],"3":[174,215,239],"(n=2)":[178],"\u03bcCi/kg":[179,227,242,392],"(total":[180],"administered":[181],"activity,":[182],"23\u2013402":[183],"\u03bcCi).":[184],"No":[185],"acute":[186],"toxicities":[187,260],"seen.":[189,289],"Myelosuppression":[190],"most":[193],"common":[194],"toxicity;":[195],"median":[197,275],"time":[198],"resolution":[200],"grade":[202,256,265],"leukopenia":[204],"26":[206],"days":[207,221],"(range,":[208,280],"0\u201371":[209],"days).":[210],"DLT":[211],"patients,":[216,251],"including":[217,373],"myelosuppression":[218],"lasting":[219],">35":[220],"patient":[224],"receiving":[225],"death":[229],"due":[230],"sepsis":[232],"levels.":[244,426],"Febrile":[245],"neutropenia":[246],"had":[255,378],"3/4":[257],"bacteremia.":[258],"Extramedullary":[259],"transient":[264],"2/3":[266],"liver":[267],"function":[268],"abnormalities":[269],"patients.":[272],"With":[273],"follow-up":[276],"mos":[279],"1\u201324":[281],"mos),":[282],"no":[283],"evidence":[284],"radiation":[286],"nephritis":[287],"analyzed":[291],"plasma":[292,316],"pharmacokinetics":[293],"gamma":[295],"counting":[296],"energy":[298],"windows":[299],"for":[300],"daughters":[302],"225Ac,":[304],"francium-221":[305],"(221Fr)":[306],"213Bi.":[308],"Two-phase":[309],"elimination":[310],"kinetics":[311],"mean":[315],"t\u00bd-\u03b1":[317],"t\u00bd-\u03b2":[319],"1.9":[321],"35":[323],"hours,":[324],"respectively.":[325],"These":[326],"results":[327],"similar":[329],"other":[331],"lintuzumab":[332],"constructs":[333],"labeled":[334],"long-lived":[336],"radioisotopes.":[337],"Peripheral":[338],"blood":[339],"blasts":[340],"eliminated":[342],"9":[344],"14":[346],"evaluable":[347,367],"(64%),":[349],"only":[351],"\u22651":[355],"\u03bcCi/kg.":[356],"Bone":[357],"marrow":[358,395],"blast":[359,380,396],"reductions":[360,397],"8":[364],"12":[366],"(67%)":[369],"weeks,":[372],"6":[374],"(50%)":[376],"who":[377],"reduction":[381],"\u226550%.":[383],"Three":[384],"1,":[388],"3,":[389],"achieved":[393],"bone":[394],"\u22645%.":[399],"Conclusions:":[400],"This":[401],"first":[404],"study":[405],"show":[407],"that":[408],"therapy":[409],"targeted":[412],"\u03b1-particle":[413],"generator":[414],"feasible":[416],"humans.":[418],"antileukemic":[421],"across":[423],"all":[424],"Accrual":[427],"this":[429],"continues":[431],"define":[433],"MTD.":[435],"Disclosures:":[436],"Jurcic:":[437],"Actinium":[438],"Pharmaceuticals,":[439,454,460,469],"Inc.:":[440,455,461,470],"Membership":[441,471],"on":[442,472],"an":[443,473],"entity's":[444,474],"Board":[445,475],"Directors":[447,477],"advisory":[449,479],"committees,":[450,480],"Research":[451,457,484],"Funding.":[452,458,485],"McDevitt:Actinium":[453],"Consultancy,":[456],"Cicic:Actinium":[459],"Employment,":[462],"Equity":[463],"Ownership,":[464],"Patents":[465,481],"&":[466,482],"Royalties.":[467],"Scheinberg:Actinium":[468],"Royalties,":[483]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2017-02-03T00:00:00"}